SG11201610731VA - A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection - Google Patents
A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infectionInfo
- Publication number
- SG11201610731VA SG11201610731VA SG11201610731VA SG11201610731VA SG11201610731VA SG 11201610731V A SG11201610731V A SG 11201610731VA SG 11201610731V A SG11201610731V A SG 11201610731VA SG 11201610731V A SG11201610731V A SG 11201610731VA SG 11201610731V A SG11201610731V A SG 11201610731VA
- Authority
- SG
- Singapore
- Prior art keywords
- dengue virus
- fragments
- immunogenic composition
- structural proteins
- composition against
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
- C07K14/1816—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus), border disease virus
- C07K14/1825—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18441—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18441—Use of virus, viral particle or viral elements as a vector
- C12N2760/18443—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14305984.8A EP2959915A1 (en) | 2014-06-23 | 2014-06-23 | A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection |
PCT/EP2015/064010 WO2015197565A1 (en) | 2014-06-23 | 2015-06-22 | A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201610731VA true SG11201610731VA (en) | 2017-01-27 |
Family
ID=51062758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201610731VA SG11201610731VA (en) | 2014-06-23 | 2015-06-22 | A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection |
Country Status (12)
Country | Link |
---|---|
US (2) | US10316066B2 (en) |
EP (2) | EP2959915A1 (en) |
JP (1) | JP6486973B2 (en) |
KR (1) | KR102557390B1 (en) |
CN (1) | CN107074913B (en) |
AU (1) | AU2015279375B2 (en) |
BR (1) | BR112016030326B1 (en) |
CA (1) | CA2952531C (en) |
MX (1) | MX2017000169A (en) |
PH (1) | PH12016502554B1 (en) |
SG (1) | SG11201610731VA (en) |
WO (1) | WO2015197565A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3331559A4 (en) * | 2015-08-03 | 2019-03-06 | The United States of America as represented by the Secretary of the Army, Walter Reed Army Institute Of Research (WRAIR) | Immune enhancing recombinant dengue protein |
CN105801674B (en) * | 2016-04-05 | 2019-03-12 | 首都医科大学 | Dengue virus E protein blocking peptide P7 and its application |
CN105777877B (en) * | 2016-04-05 | 2019-03-12 | 首都医科大学 | Dengue virus E protein blocking peptide P4 and its application |
US11020473B2 (en) | 2016-06-24 | 2021-06-01 | Institut Pasteur | Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases |
US11305003B2 (en) * | 2017-11-09 | 2022-04-19 | Institut Pasteur | Zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition |
US11576962B2 (en) | 2017-12-21 | 2023-02-14 | Green Biomed, Inc. | Cross-immunizing antigen vaccine and method for preparation thereof |
US20220001001A1 (en) * | 2018-07-13 | 2022-01-06 | University Of Georgia Research Foundation | Broadly reactive immunogens of dengue virus, compositions, and methods of use thereof |
EP4208193A1 (en) * | 2020-09-01 | 2023-07-12 | Helmholtz-Zentrum für Infektionsforschung GmbH | Multi-patch vaccines and immunogenic compositions, methods of production and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE610436T1 (en) | 1991-11-21 | 1995-08-03 | Common Services Agency | Detection of the hepatis-C virus. |
DK1375512T3 (en) | 2002-06-20 | 2009-10-26 | Pasteur Institut | Infectious cDNA of an approved measles virus vaccine strain. Use for immunogenic compositions |
EP1375670B1 (en) | 2002-06-20 | 2013-06-12 | Institut Pasteur | Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions |
ZA200900483B (en) * | 2006-07-14 | 2010-03-31 | Sanofi Pasteur Biologics Co | Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins |
EP2545071A2 (en) * | 2010-03-09 | 2013-01-16 | Maksyutov, Amir | Polyepitope constructs and methods for their preparation and use |
WO2011163628A2 (en) * | 2010-06-24 | 2011-12-29 | La Jolla Institute For Allergy And Immunology | Dengue virus (dv) polypeptide sequences, t cell epitopes and methods and uses thereof |
EP2723372A4 (en) * | 2011-06-24 | 2015-03-04 | Jolla Inst Allergy Immunolog | Protection against dengue virus and prevention of severe dengue disease |
-
2014
- 2014-06-23 EP EP14305984.8A patent/EP2959915A1/en not_active Withdrawn
-
2015
- 2015-06-22 BR BR112016030326-1A patent/BR112016030326B1/en active IP Right Grant
- 2015-06-22 MX MX2017000169A patent/MX2017000169A/en unknown
- 2015-06-22 JP JP2016574959A patent/JP6486973B2/en active Active
- 2015-06-22 CN CN201580044335.6A patent/CN107074913B/en active Active
- 2015-06-22 US US15/320,033 patent/US10316066B2/en active Active
- 2015-06-22 AU AU2015279375A patent/AU2015279375B2/en active Active
- 2015-06-22 WO PCT/EP2015/064010 patent/WO2015197565A1/en active Application Filing
- 2015-06-22 CA CA2952531A patent/CA2952531C/en active Active
- 2015-06-22 EP EP15735644.5A patent/EP3157555B1/en active Active
- 2015-06-22 KR KR1020177001998A patent/KR102557390B1/en active IP Right Grant
- 2015-06-22 SG SG11201610731VA patent/SG11201610731VA/en unknown
-
2016
- 2016-12-20 PH PH12016502554A patent/PH12016502554B1/en unknown
-
2019
- 2019-03-21 US US16/360,970 patent/US11034730B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2952531A1 (en) | 2015-12-30 |
US20190300578A1 (en) | 2019-10-03 |
EP3157555A1 (en) | 2017-04-26 |
BR112016030326A2 (en) | 2017-10-24 |
US20170158740A1 (en) | 2017-06-08 |
US11034730B2 (en) | 2021-06-15 |
KR102557390B1 (en) | 2023-07-19 |
CN107074913B (en) | 2022-02-25 |
JP6486973B2 (en) | 2019-03-20 |
JP2017520252A (en) | 2017-07-27 |
CN107074913A (en) | 2017-08-18 |
PH12016502554A1 (en) | 2017-04-10 |
MX2017000169A (en) | 2017-06-29 |
CA2952531C (en) | 2021-12-28 |
KR20170020513A (en) | 2017-02-22 |
EP3157555B1 (en) | 2024-05-15 |
BR112016030326B1 (en) | 2023-10-31 |
AU2015279375A1 (en) | 2017-01-05 |
US10316066B2 (en) | 2019-06-11 |
WO2015197565A1 (en) | 2015-12-30 |
PH12016502554B1 (en) | 2017-04-10 |
EP2959915A1 (en) | 2015-12-30 |
AU2015279375B2 (en) | 2019-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201610731VA (en) | A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection | |
HK1247636A1 (en) | Rna guided eradication of human jc virus and other polyomaviruses | |
ZA201701851B (en) | Fmdv recombinant vaccines and uses thereof | |
HUS2300022I1 (en) | Compositions and methods for dengue virus chimeric constructs in vaccines | |
ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
SG11201606624WA (en) | Antibody moleules to dengue virus and uses thereof | |
EP2985288A4 (en) | Porcine pseudorabies virus, vaccine composition and preparation method and use thereof | |
SG11201610443WA (en) | Influenza virus vaccines and uses thereof | |
SG11201702116VA (en) | Viral rna segments as immunomodulatory agents and vaccine components | |
SG11201703366RA (en) | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | |
HK1255379A1 (en) | Hepatitis c virus immunogenic compositions and methods of use thereof | |
IL287985A (en) | Koc1-derived peptide and vaccine including same | |
SG11201510266SA (en) | Dengue virus vaccine compositions and methods of use thereof | |
SG11201510617WA (en) | Methods and compositions for dengue virus vaccines | |
SG11201505930TA (en) | Porcine parvovirus 5b, methods of use and vaccine | |
HK1244534A1 (en) | Recombinant borrelia proteins and methods of use thereof | |
SG11202004234SA (en) | A zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition | |
EP3131875A4 (en) | Allenamide as an orthogonal handle for selective modification of cysteine in peptides and proteins | |
SG11201704942QA (en) | Dengue virus vaccine compositions and methods of use thereof | |
SG11201706342PA (en) | An epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses | |
ME03399B (en) | 2-aryl-4-hydroxy-1,3-thiazole derivatives useful as trpm8-inhibitors in treatment of neuralgia, pain, copd and asthma | |
SG11201606237RA (en) | Hcv chimeric vaccine with influenza virus as vector and preparation method thereof | |
IL249705B (en) | Influenza virus vaccines and uses thereof | |
IL249704A0 (en) | Influenza virus vaccines and uses thereof | |
TH1501005277A (en) | Composition and methods for dengue virus chimeric constructs in vaccines. |